Phase 2 Atrial fibrillation trials recruiting now

All Atrial fibrillation trials, every phase

Other phases for Atrial fibrillation

Phase 2 Atrial fibrillation trials

• A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
  NCT07217067 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 40 locations
• A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
  NCT07625215 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 29 locations
• Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
  NCT06067438 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Amiodarone-Infused CardiaMend Patches for the Prevention of New-Onset POAF in Cardiac Surgery Subjects
  NCT06730828 · Phase: Phase 1, Phase 2 · Ages: 20 Years to 85 Years · Sex: All (male and female) · 1 location
• Anthocyanin-Rich Table Grape Powder for Prophylaxis of Post-Operative Atrial Fibrillation
  NCT05991700 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 79 Years · Sex: All (male and female) · 1 location
• Caffeine Consumption and Rate Control in Permanent Atrial FIBrillation: The CAFIB Trial
  NCT07738523 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Chloroquine for Patients With Symptomatic Persistent Atrial Fibrillation: A Prospective Pilot Study
  NCT02932007 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
  NCT07267949 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 44 locations
• Dose Escalation Study to Assess Safety, Tolerability, and Efficacy of Budiodarone Treatment With Non-permanent Atrial Fibrillation
  NCT07792239 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 4 locations
• EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined Source
  NCT06715449 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Finerenone After Catheter Ablation to Reduce Atrial Fibrillation Recurrence
  NCT07799519 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients
  NCT06279793 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 10 locations
• RiLuzole to Reduce Atrial FIb Study Using Holter Monitoring
  NCT05292209 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose Metabolism
  NCT07482020 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
  NCT07175428 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 81 locations
• TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
  NCT06802081 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.